MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A

Journal of Cell Biology

Volumn 168, Issue 1, 2005, Pages 35-40

  Loercher, Amy E ^a   Tank, Elizabeth M H ^a   Delston, Rachel B ^a   Harbour, J William ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PROTEIN P16INK4A; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA-BINDING PROTEINS; FIBROBLASTS; GENE SILENCING; HUMANS; MELANOCYTES; MICE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; RETINOBLASTOMA PROTEIN; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 12144254034     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200410115     Document Type: Article

References (23)

1. Bear, J., Y. Hong, and M. Schartl. 2003. Mitf expression is sufficient to direct differentiation of medaka blastula derived stem cells to melanocytes. Development. 130:6545-6553.
2. Brugarolas, J., K. Moberg, S.D. Boyd, Y. Taya, T. Jacks, and J.A. Lees. 1999. Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation. Proc. Natl. Acad. Sci. USA. 96:1002-1007.
3. Chin, L., G. Merlino, and R.A. DePinho. 1998. Malignant melanoma: modern black plague and genetic black box. Genes Dev. 12:3467-3481.
4. Harbour, J.W., L. Worley, D. Ma, and M. Cohen. 2002. Transducible peptide therapy for uveal melanoma and retinoblastoma. Arch. Ophthalmol. 120:1341-1346.
5. Ikeda, M.A., L. Jakoi, and J.R. Nevins. 1996. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA. 93:3215-3220.
6. Kastner, A., X. Espanel, and G. Brun. 1998. Transient accumulation of retinoblastoma/E2F-1 protein complexes correlates with the onset of neuronal differentiation in the developing quail neural retina. Cell Growth Differ. 9:857-867.
7. Kitagawa, M., H. Higashi, H.K. Jung, T.I. Suzuki, M. Ikeda, K. Tamai, J. Kato, K. Segawa, E. Yoshida, S. Nishimura, and Y. Taya. 1996. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15:7060-7069.
8. Lipinski, M.M., and T. Jacks. 1999. The retinoblastoma gene family in differentiation and development. Oncogene. 18:7873-7882.
9. Ma, D., P. Zhou, and J.W. Harbour. 2003. Distinct mechanisms for regulating the tumor suppressor and antiapoptotic functions of Rb. J. Biol. Chem. 278:19358-19366.
10. McGill, G.G., M. Horstmann, H.R. Widlund, J. Du, G. Motyckova, E.K. Nishimura, Y.L. Lin, S. Ramaswamy, W. Avery, H.F. Ding, et al. 2002. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell. 109:707-718.
11. Monzon, J., L. Liu, H. Brill, A.M. Goldstein, M.A. Tucker, L. From, J. McLaughlin, D. Hogg, and N.J. Lassam. 1998. CDKN2A mutations in multiple primary melanomas. N. Engl. J. Med. 338:879-887.
12. INK4 function. Nat. Genet. 10:114-116.
13. Serrano, M., G.J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 366:704-707.
14. Sherr, C.J. 2004. Principles of tumor suppression. Cell. 116:235-246.
15. Sorrentino, V., R. Pepperkok, R.L. Davis, W. Ansorge, and L. Philipson. 1990. Cell proliferation inhibited by MyoD1 independently of myogenic differentiation. Nature. 345:813-815.
16. Ink4a in melanocyte senescence and differentiation. J. Natl. Cancer Inst. 94:446-454.
17. Tachibana, M., K. Takeda, Y. Nobukuni, K. Urabe, J.E. Long, K.A. Meyers, S.A. Aaronson, and T. Miki. 1996. Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics. Nat. Genet. 14:50-54.
18. Takebayashi, K., K. Chida, I. Tsukamoto, E. Morii, H. Munakata, H. Arnheiter, T. Kuroki, Y. Kitamura, and S. Nomura. 1996. The recessive phenotype displayed by a dominant negative microphthalmia-associated transcription factor mutant is a result of impaired nucleation potential. Mol. Cell. Biol. 16:1203-1211.
19. INK4a expression in uveal melanoma. Cancer Res. 61:5303-5306.
20. Widlund, H.R., and D.E. Fisher. 2003. Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival. Oncogene. 22:3035-3041.
21. Yasumoto, K., H. Mahalingam, H. Suzuki, M. Yoshizawa, and K. Yokoyama. 1995. Transcriptional activation of the melanocyte-specific genes by the human homolog of the mouse Microphthalmia protein. J. Biochem. (Tokyo). 118:874-881.
22. Yavuzer, U., E. Keenan, P. Lowings, J. Vachtenheim, G. Currie, and C.R. Goding. 1995. The Microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocytespecific transcription. Oncogene. 10:123-134.
23. Yu, B.D., M. Becker-Hapak, E.L. Snyder, M. Vooijs, C. Denicourt, and S.F. Dowdy. 2003. Distinct and nonoverlapping roles for pRB and cyclin D: cyclin-dependent kinases 4/6 activity in melanocyte survival. Proc. Natl. Acad. Sci. USA. 100:14881-14886.